Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I study of SOX therapy after preoperative chemoradiotherapy in lower advanced rectal cancer
jRCTs061210016Phase 1Completed
- Start
- Jun 2021
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of tegafur and oxaliplatin in rectal cancer. Primary endpoint: Adverse events in SOX therapy. Started Jun 2021; status: completed.
02
Drugs
tegafuroxaliplatin
03
Conditions
rectal cancer
Beyond the preview
Go deeper on jRCTs061210016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061210016.